A comprehensive meta-analysis of eight GLP-1 RA CVOTs revealed several critical findings: 14% reduction in major adverse cardiovascular events (MACE: cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke) [3] 13% reduction in cardiovascular death [3] 10% reduction in all-cause mortality [3] 11% reduction in hospitalization for heart failure [3] Post-hoc analyzes from LEADER and SUSTAIN-6 revealed that cardiovascular benefits extended across the spectrum of body mass index categories, indicating efficacy regardless of baseline weight [2]
Read more about: GLP-1s
While this came as a surprise to most everybody in the country, the reality of this legendary coachs retirement is now really sinking in
He hints that what Medvi is doing is likely illegal They have (over) 800 ads running right now from fake doctors (and another 4,000 running with fake testimonials and from fake organisations), he wrote on X
Why the numbers work: 2.8% monthly attrition vs 6-8% industry average: lower hidden retraining costs over multi-year engagements 90% CSAT: fewer escalations, fewer repeat contacts, stronger patient experience metrics 5-year average client partnerships: onboarding investment amortizes over a much longer value cycle SOC 2, HIPAA, GDPR, ISO 27001 certified: compliance is built in, not bolted on after contracting
